Biocon to add 3,500 jobs by 2014

Tags: Knowledge
Biotechnology major Biocon Group said it expects to double its headcount to about 8,000 in the next four years. Led by significant opportunity in India, it is also aiming to hit the $1 billion revenue mark in the next three years, according to company chairman and managing director Kiran Mazumdar-Shaw.

The Bangalore-based gr-oup has nearly doubled its employee base to 4,500 in the last four years. As of March 2006, the total headcount was 1,839, which grew to over 4,000 as of March 2010 at a CAGR of 25 per cent. This is much lesser than the CAGR of revenue growth of 32 per cent, from Rs 793 crore in FY06 to Rs 2,405 in FY10.

About five per cent of Biocon’s employees have PhD degrees, 41 per cent have a master’s degree in science and the remaining are graduates with a bachelor’s degree in science, commerce or arts. About 15 per cent of Biocon employees are women.

Speaking to Financial Chronicle on the sidelines of Bangalore India Bio 2010 conference, Mazumdar-Shaw refused to comment on whether the Euro currency crisis would have a negative impact on Biocon’s revenue. She said that the Indian biotech sector, which attracted investment of Rs 100 crore last year, will attract about $1 billion investment in couple of years.

Referring to regulatory challenges the sector is facing, Mazumdar-Shaw felt that the case of BT Brinjal shows that there is no proper regulatory structure in place to take a call on approval. “There are similar issues in bio-pharma space. We are good at generic, but not at new products,” she said.

Post new comment

E-mail ID will not be published
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.

EDITORIAL OF THE DAY

  • Amit Shah deserved to be crowned President of India, some say

    The Bharatiya Janata Party is now firmly in the hands of Modi’s alter ego, which in plain English means ‘another side of oneself, a second self’

FC NEWSLETTER

Stay informed on our latest news!

INTERVIEWS

GV Nageswara Rao

MD & CEO, IDBI Federal Life

Timothy Moe

Goldman Sachs

Chander Mohan Sethi

CMD, Reckitt Benckiser India

COLUMNIST

Arun Nigavekar

Necessary yet inadequate boost to education

The finance minister, in the very first minutes of his ...

Zehra Naqvi

We must overcome the fear of death

It is the biggest irony that the only thing that’s ...

Dharmendra Khandal

Jawai leopards and locals can coexist peacefully

At first glance, the Jawai landscape seems like a large ...

INTERVIEWS

William D. Green

Chairman & CEO, Accenture